NCT00084253 - Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2006

Conditions

HIV Infections

Interventions

DRUG

Atazanavir/ Stavidine / Lamivudine

Capsules, Oral, ATV (2 x 200 mg) QD + 3TC (2 x 150 mg) QD + Zerit XR (1 x 100 mg) QD, Once daily, 96 weeks.

DRUG

Atazanavir-Ritonavir/ Stavidine / Lamivudine

Capsules, Oral, ATV (2 x 150 mg) QD + RTV (1 x 100 mg) QD + 3TC (2 x 150 mg) QD + Zerit XR (1 x 100 mg) QD\*, Once daily, 96 weeks.

Trial Locations (1)

Various locations within the US, Call For Information